Wyeth seeks total victory in vaccine patent battle with Merck Sharp & Dohme

Allens 2021-01-15 8:53 am By Miklos Bolza | Sydney

Please login to bookmark

Pfizer unit Wyeth is seeking to overturn part of a judge’s decision in its high-stakes patent dispute with Merck Sharp & Dohme that found claims in two of its patents relating to the blockbuster Prevnar 13 pneumococcal vaccine were invalid.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au